Target intelligence / Profile preview

Streptococcal glucosyltransferase (Gtf (general); GtfB, GtfC, GtfD (specific enzymes))

Target
Gtf (general); GtfB, GtfC, GtfD (specific enzymes)
Molecular classification
Enzyme, Glycosyltransferase, Glycoside hydrolase family 70 (GH70), Member of α-amylase superfamily
01

Overview

Streptococcal glucosyltransferase refers to a family of enzymes (primarily GtfB, GtfC, and GtfD) produced by *Streptococcus mutans* and related oral streptococci[5][6][7]. These enzymes catalyze the transfer of glucose residues from sucrose to form extracellular glucans, which are key structural components of dental biofilms and are essential for bacterial colonization and virulence in dental caries[5][7]. Gtfs belong to glycoside hydrolase family 70 and share a conserved catalytic domain (for sucrose binding and cleavage) with a variable C-terminal region for glucan binding[7]. They are well-recognized therapeutic targets for caries prevention and control strategies focused on disrupting biofilm formation. Inhibitors of Gtfs are being explored as anticaries agents, but clinical translation is complicated by selectivity and safety considerations[5][6][7].

Other names
GlucosyltransferaseGtfdextransucraseGTaseGtfBGtfCGtfD
02

Mechanism of action

Drugs/inhibitors block enzymatic activity, suppressing synthesis of water-soluble and water-insoluble glucans, thus reducing biofilm formation[5][6]

03

Biological functions

Synthesis of extracellular polysaccharides (glucans) from sucroseBiofilm formation (critical for bacterial adherence to surfaces)Carbohydrate metabolism (sucrose to glucose polymers)
04

Disease associations

InfectionDental caries (tooth decay)
05

Safety considerations

Challenges in targeting Gtfs therapeutically due to their similarity with host enzymes (potential for off-target effects); disrupting oral microbiota balance[5]
06

Interacting drugs

Some small molecule inhibitors (e.g., catechins such as epigallocatechin gallate, chlorhexidine, apigenin, and other natural products inhibit Gtfs)[6]
07

Biomarkers

Presence and/or activity of Gtf enzymes can serve as a biomarker for cariogenicity (risk of dental caries), particularly in *Streptococcus mutans*[7]

Beyond the preview

Go deeper on Streptococcal glucosyltransferase (Gtf (general); GtfB, GtfC, GtfD (specific enzymes)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcal glucosyltransferase (Gtf (general); GtfB, GtfC, GtfD (specific enzymes)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call